Approval · Notice of Compliance 25899 · 2021
EUCRISA: Notice of Compliance 25899
Issued May 18, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25899
- Date
- May 18, 2021
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To change the minimum approved age for the use of EUCRISA from 2 years of age to 3 months of age
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EUCRISA | Not yet assigned | — |
Medicinal ingredients
- CRISABOROLE 2 PER